AcariaHealth selected to dispense ELEVIDYS™, the First Gene Therapy FDA Approved to Treat Duchenne Muscular Dystrophy

ORLANDO, Fla., July 6, 2023 /PRNewswire/ — AcariaHealth, the fifth largest specialty pharmacy in the U.S., announced today that it has been selected by Sarepta Therapeutics, Inc. as part of the limited distribution network for ELEVIDYS (delandistrogene moxeparvovec-rokl). ELEVIDYS, an…